高血压管理的进步:来自最新欧洲指南的见解
Marco Zuin1,2,3, Chiara Tognola4, Alessandro Maloberti4,5
1Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Journal of cardiovascular development and disease
|April 25, 2025
概括
动脉高血压影响30-45%的欧洲人,随着年龄的增长而增加. 本综述根据新的欧洲指南,回答了关于诊断和治疗高血压的常见问题.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 动脉高血压是心血管疾病和死亡的主要可预防风险因素.
- 在欧洲,患病率为30-45%,随着年龄的增长而显著上升.
- 新的欧洲指南为高血压患者的管理提供了最新的建议.
研究的目的:
- 为了回答有关动脉高血压诊断的常见问题.
- 根据最新的欧洲指南概述高血压的管理和治疗.
主要方法:
- 对当前的欧洲指导方针进行集中审查.
- 综合处理常见临床问题的信息.
主要成果:
- 该审查涉及高血压诊断的关键方面.
- 它详细介绍了高血压患者目前的管理和治疗策略.
结论:
- 遵守最新的欧洲指南对于有效的高血压管理至关重要.
- 本综述是临床医生面临常见高血压相关问题的实用资源.
相关概念视频
01:18Hypertension and Regulation of Blood Pressure
1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
379
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
379
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
85
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
85
01:28Factors affecting Blood pressure
2.7K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
2.7K